CB Therapeutics is producing cannabinoids for use as nutraceuticals, topical treatments, cosmetics, food and beverage and in animal-health. Our biosynthetic production method in yeast, delivers cannabinoids that are identical to those extracted from plants, such as cannabis or hemp. But our cannabinoids are pure, consistent, not contaminated by insecticides or other chemical or organic material for biopharmaceutical testing and clinical research.

We are currently producing these Cannabinoids for commercial sale.
Please inquire for details.

CBC


CBC has been shown to provide these therapeutic benefits:
Pain
Inflammation
Irritable Bowel Syndrome (IBS)
Neuro-Protection
Skin Health
Mild Anxiety (10X greater than CBD)
Others

CBG


CBG has been shown to provide these therapeutic benefits:
Glaucoma
Irritable Bowel Syndrome (IBS)
Neuro-Protection
Microbial Control
Appetite Stimulation
Others

CBT


CBT has been shown to provide these therapeutic benefits:
Glaucoma
Other potential benefits
require additional research

These therapeutic benefits have not been evaluated by the FDA.


Cannabinoid products in our pipeline that are coming soon. Please inquire for availability.

CBN


CBDA


CBGA


CBCA


CBD


THCV


THCVA


We are currently developing tryptamines such as psilocybin, DMT and their analogs for use in accredited clinical trials. If you are interested in any tryptamine for the use in legal clinical research, please Contact Us.